Cash and cash equivalents as of March 31, 2024, totaled approximately $66.6 million.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDSB:
- PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results
- PDSB Upcoming Earnings Report: What to Expect?
- PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer
- PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024
- PDS Biotechnology Announces Details of Virtual KOL Event